In addition to signals delivered by pattern recognition receptors, infections can stimulate innate immunity through the host response to tissue injury (danger signals). We have been examining the possible role of one such pathway (the ER stress response) in the initiation of innate cytokine production. Maintaining normal cell physiology requires constant protein synthesis and proper folding, processes that occur in the endoplasmic reticulum (ER). Improperly folded proteins accumulate within the ER and generate perturbations known as ER stress that engage the unfolded protein response (UPR). Although not fully understood, downstream effector mechanisms of the UPR promote a wide range of inflammatory pathologies such as neurodegenerative disorders, diabetes and obesity. In the present work we have characterize the link between the ER stress response and the production of interleukin-1beta (IL-1b), a pro-inflammatory cytokine known to play a role in those conditions as well as in innate immunity to infection. Using a well-established model of ER stress induced by treatment with the drugs tunicamycin or thapsigargin, we showed in vitro that macrophages undergoing ER stress are able to potently activate pro-IL1b in response to stimulation with LPS but not other TLR agonists. Interestingly, the classical Nlrp3 inflammasome which is usually required for the generation of mature IL-1b is dispensable since maturation of pro-IL1beta does not require the critical inflammasome adaptor protein ASC or its effector caspase-1. In contrast, our results indicate that processing of pro-IL1b is dependent on caspase-8 since production of the mature cytokine is completely abrogated in macrophages lacking this non-inflammasome associated protease. Intriguingly, we found that the UPR proteins XBP1 and CHOP are not required for Caspase-8 activation, nor is the TLR4 adaptor molecule MyD88. Instead, we observed that the alternative TLR4 adaptor TRIF is fully required and thus could recruit Rip1, a signaling intermediate involved in Caspase-8 activation. This novel pathway is of interest as it could underlie the induction of IL-1-driven tissue pathology in different disease settings and could serve as a mechanism by which infections such as Mtb drive IL-1b responses. As noted in previous annual reports and publications from our group we have been studying the role played by both exogenous and endogenous Type I interferons in promoting murine infection with Mycobacterium tuberculosis. A strong association between Type I interferons and their induced genes and active tuberculosis has also been documented in human Mtb infection by OGarra and colleagues. Such findings have raised the question of whether concomitant viral infections that trigger Type I IFN production could exacerbate active MTb infection and/or re-activate latent tuberculosis. This question is of particular relevance to influenza where much of the actual severe disease is caused by bacterial super-infection. In a collaboration with the OGarra group, we addressed this question in TB and showed that prior exposure of mice to influenza A, followed by M. tuberculosis infection, leads to enhanced mycobacterial growth and decreased host survival. In addition, we found that that following concurrent M. tuberculosis/influenza co-infection, mycobacterial growth is enhanced and this increased susceptibility is reversed in mice lacking the IFN alpha/beta receptor. Together, these findings argue that prior or concomitant viral infection can promote M. tuberculosis infection and point to the involvement of Type I IFN in this process.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Riteau, Nicolas; Radtke, Andrea J; Shenderov, Kevin et al. (2016) Water-in-Oil-Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6-Dependent Pathway. J Immunol 197:3884-3893
Arbore, Giuseppina; West, Erin E; Spolski, Rosanne et al. (2016) T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science 352:aad1210
Riteau, Nicolas; Sher, Alan (2016) Chitosan: An Adjuvant with an Unanticipated STING. Immunity 44:522-4
McNab, Finlay; Mayer-Barber, Katrin; Sher, Alan et al. (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87-103
Mayer-Barber, Katrin D; Sher, Alan (2015) Cytokine and lipid mediator networks in tuberculosis. Immunol Rev 264:264-75
Cardone, Marco; Dzutsev, Amiran K; Li, Hongchuan et al. (2014) Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation. PLoS One 9:e114516
Shenderov, Kevin; Riteau, Nicolas; Yip, Ronald et al. (2014) Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1β in response to TLR4 stimulation through a caspase-8- and TRIF-dependent pathway. J Immunol 192:2029-33
Redford, Paul S; Mayer-Barber, Katrin D; McNab, Finlay W et al. (2014) Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis 209:270-4
Mayer-Barber, Katrin D; Andrade, Bruno B; Oland, Sandra D et al. (2014) Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511:99-103
Shenderov, Kevin; Barber, Daniel L; Mayer-Barber, Katrin D et al. (2013) Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome. J Immunol 190:5722-30

Showing the most recent 10 out of 22 publications